Introduction
A major challenge to technologic development in the twenty-first century will be to prevent environmental and occupational diseases, which too often accompanied the introduction of new technologies in centuries past.
The catalogue of diseases caused by new technologic developments includes lead poisioning, which occurred in the ancient Greeks and Romans using lead acetate to sweeten wine (1); mercury poisoning, present in the Almaden Spanish miners during the Middle Ages (2); lead poisoning in Renaissance potters (3); black lung in coal miners (2) ; and silicosis in English foundry workers and grinders during the Industrial Revolution (4). In the modern era industrial toxic conditions include bladder cancer in dye workers (5) , phossy jaw in matchmakers (6) , mesothelioma and lung cancer in asbestos workers (7) , encephalopathy and neurotoxicity in pesticide manufacturers (8, 9) , leukemia and solid tumors in persons exposed to ionizing radiation (10) , and leukemia and lymphoma in benzene workers (11, 12) .
Typically, when a new technology is first introduced, it is hailed as safe. No associated disease is seen in the initial months or years following its use; presumably, this is due either to the fact that a latency (incubation) period must elapse before the appearance of illness or that an illness associated with the technology has simply not yet been recognized. When disease associated with a new technology is finally observed, the symptoms associated with high-dose exposure are usually the first to be perceived. Frequently, initial recognition is made by an astute clinician (13) (14) , angiosarcoma of the liver in vinyl chloride workers (15) , or lung cancer in workers exposed to bischloromethyl ether (16) . Initial clinical recognition is followed by epidemiologic confirmation and toxicologic corroboration. Additionally, and with increasing frequency, quantitative risk assessment is undertaken and a dose-response relationship is established.
Recent Environmental Diseases in Industry
Two recent examples of environmental diseases that resulted from the introduction of new technologies are the kepone disaster, associated with the manufacture of a new pesticide (9) , and epidemic neurologic paralysis of the urinary bladder, associated with the introduction of a new catalyst in plastic manufacture (17 In the epidemiological analysis, data were obtained on 208 of the 230 plant workers. The first case of bladder dysfunction occurred in August 1977 (shortly after the introduction of DMAPN) in a female mold cleaner who worked close to an area where hot polyurethane foam with the new catalyst was removed from molds. The frequency of subsequent cases increased roughly in parallel with the use of the catalyst.
The highest incidence of bladder dysfunction occurred in assembly line workers. Among the 166 production workers, 104 (63%) had symptoms. No cases occurred among the 42 nonproduction employees. Twenty cases were noted in 36 women production workers (55.6%), and 84 cases in 130 men (64.5%).
Five men and three women were referred for detailed neurologic and urologic evaluation. On neurologic examination, seven of these eight patients had abnormalities affecting the distal lower extremities. Five had a sensory neuropathy and two had a mixed sensorimotor neuropathy. On electrophysiologic testing, one patient had prolonged peroneal latency and reduced evoked muscle action potentials; these findings were corroborated by marked muscle atrophy in the feet. Three patients had a slowing of sural sensory nerve conduction, and one showed a reduced amplitude of the sural nerve action potential. There patients had prolonged sacral latency, and two of the three had evidence by electromyography of partial denervation of the external anal sphincter.
Discussion
An exponential increase has occurred since World War II in developing and producing new synthetic chemicals. During this 40-year period, chemical production capacity has increased worldwide by 350-fold (18) . More than 1000 new chemical compounds are now produced each year; they are added to the 60,000 pure chemicals and the two million mixtures, formulations, and blends already in commercial use (19 
